[1] HIROSHI KASE. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases[J]. Biochemical and biophysical research communications, 1987, 142 2: Pages 436-440. DOI:
10.1016/0006-291x(87)90293-2[2] YOSHIAKI HASHIMOTO . Potent and preferential inhibition of Ca2+ / calmodulin-dependent protein kinase II by K252a and its derivative, KT5926[J]. Biochemical and biophysical research communications, 1991, 181 1: Pages 423-429. DOI:
10.1016/s0006-291x(05)81436-6[3] M M BERG. K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity.[J]. The Journal of Biological Chemistry, 1992, 267 1: 13-16.
[4] U T RÜEGG G M B. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.[J]. Trends in pharmacological sciences, 1989, 10 6: 218-220. DOI:
10.1016/0165-6147(89)90263-0[5] L S CHIN. K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c.[J]. Cancer Investigation, 1999, 17 6: 391-395. DOI:
10.3109/07357909909021430